Study how autoantibodies affect virus levels in severe lung infections
Part of Infections, Lungs & breathing clinical trials.
This study measures blood immune “autoantibodies” that may affect how much virus is in the body during severe respiratory infections. It may help doctors understand which patients are more likely to have higher virus levels and could guide future treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age-eligible adult or pediatric and able to be enrolled in the study hospital ICU
- You are hospitalized in an intensive care unit for a severe breathing problem needing oxygen
- Your infection is influenza, RSV, or SARS-CoV-2 (COVID-19) diagnosed within the last 7 days by a test
- Your oxygen need is high enough to keep oxygen saturation at least 90% (or child criteria like SpO2 below 92% on room air)
- If you are immunosuppressed from certain recent treatments or conditions, you may be excluded
- You must be at least 30 kg as an adult (or at least 3 kg as a child) and able to consent (no refusal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study looks at how different respiratory viruses interact in hospitalized patients during the winter seasons. It does not involve any new treatment or extra tests – it just reviews existing test results to learn more about these viruses.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
This trial studies whether giving antibiotics affects recovery in adults hospitalized with moderately severe infections caused by specific viruses (influenza, parainfluenza, RSV, or hMPV). It may help show when antibiotics are helpful or unnecessary for viral airway illness.
This study looks at how the body's immune system responds to common respiratory infections like flu, RSV, and COVID-19 in people aged 60 and older. It aims to understand inflammation during these infections, which could help improve future treatments.
Hear when a new Severe Respiratory Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.